CompanyNewsHQ
The latest news from the pharmaceutical sector. Covering the latest breaking news, encompassing company news from leading pharmaceutical companies and related companies.
26 April 2021 07:10 BST Recommendation based on the SPRINT Phase II trial, which showed selumetinib reduced tumour volume in
Read moreNirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial Respiratory Syncytial Virus (RSV) is
Read moreEnspryng is recommended for approval as a treatment option for people with NMOSD from 12 years of age in the
Read moreNEW BRUNSWICK, N.J., April 23, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that vaccinations with the
Read moreJohnson & Johnson Statement on April 23 CDC Advisory Committee Meeting on Company COVID-19 Vaccine Johnson & Johnson Statement on
Read moreTHOUSAND OAKS, Calif., April 23, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) improved measures of disease severity in adults
Read moreNew Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young
Read moreEisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that Biogen (Nasdaq: BIIB) has disclosed, in its Q1
Read moreSPRING HOUSE, PENNSYLVANIA, April 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new Phase 3
Read moreFor media and investors only Issued: London UK European Commission approves GSK’s JEMPERLI (dostarlimab), the first anti-PD-1 therapy approved for
Read moreNORTH CHICAGO, Ill., April 23, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the Committee for Medicinal Products for
Read moreIf approved, ENSPRYNG will be the first and only treatment available to both adults and adolescents from 12 years of
Read moreThe COVID-19 pandemic highlights the importance of robust health systems to respond to disease outbreaks and to control other deadly
Read moreSMART study to extend data beyond patient population studied in clinical trials New clinical study to evaluate safety and efficacy
Read moreTokyo, April 23, 2021 – Gilead Sciences K.K. (Head office: Chiyoda-ku, Tokyo; President and Representative Director: Luc Hermans; “Gilead”) and
Read moreAbout 90,000 women globally die from endometrial cancer each year1 VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test
Read moreEisai Co., Ltd. MSD K.K. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and MSD K.K. (Headquarters: Tokyo, President:
Read moreIssued: London UK GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved JEMPERLI (dostarlimab-gxly), a
Read more23 Apr 2021 | Darmstadt, Germany Merck, a leading science and technology company, held its 26th Annual General Meeting in
Read moreTHOUSAND OAKS, Calif., April 22, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results
Read moreBoard of Directors approves quarterly cash dividend of $0.39 per share NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced
Read more– Multi-year strategic research collaboration leverages Obsidian’s proprietary cytoDRiVE® platform to discover controllable genetic therapies to treat serious diseases –
Read moreRevenues and core operating profit for the first quarter at ¥168.8 billion (-5.9%) and ¥65.4 billion (-11.7%), respectively Maintaining full-year
Read moreBasel, 22 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics, Inc. today announced that Roche’s wholly
Read moreTOKYO, April 22, 2021– Chugai Pharmaceutical Co., Ltd. announced that disposal of treasury shares was completed today, as we announced
Read more